Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Researchers in JAMA Network Open reviewed the total cost of producing GLP-1 medications (as well as insulin and another classes of medicines used for diabetes) with an eye toward establishing a resource-based price so that these medications could be used to treat obesity and diabetes in low and middle income countries, where noncommunicable diseases such as heart disease and diabetes take a larger toll each year
Now let us fight for you
Despite promising research, it is important to exercise caution when considering the potential benefits of GLP-1 agonists beyond diabetes and obesity
Pneumonia and dehydration were serious adverse events reported in the apitegromab group but not the placebo group
If you're not sure whether you'd qualify, the intake process will help you find out
